{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:50:53Z","timestamp":1777679453769,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fulminant disseminated tuberculosis (TB) presenting as Landouzy sepsis is rare but carries high mortality. When complicated by acute respiratory distress syndrome (ARDS) and multiorgan failure, evidence for optimal management, including extracorporeal membrane oxygenation (ECMO) and modified antituberculous regimens, remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We describe a 23-year-old man with miliary tuberculosis who developed Landouzy sepsis, ARDS, hepatic dysfunction, and refractory hypoxemia requiring veno-venous (VV) and subsequent veno-veno-venous (VVV) ECMO for six weeks. Standard anti-TB treatment for susceptible mycobacteria was withheld due to liver injury most likely related to antituberculous drug toxicity. Despite initial treatment with isoniazid, rifampicin, and ethambutol, rising bilirubin prompted rifampicin discontinuation and transition to an individualized regimen including ethambutol, isoniazid, levofloxacin, bedaquiline, and amikacin. Corticosteroid therapy was started for suspected secondary organizing pneumonia during persistent hypercapnic respiratory failure, followed by clinical improvement. The course was complicated by thrombocytopenia, pneumothorax, arrhythmia, plasma exchange\u2013dependent hyperbilirubinemia, and amikacin-associated sensorineural hearing loss. Microbiological clearance was achieved, organ dysfunction progressively recovered, and first-line therapy was successfully reintroduced after stabilization. The patient was ultimately discharged without oxygen requirement and started a rehabilitation program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case highlights that even life-threatening tuberculosis with multiorgan failure can be survivable. Early diagnosis, flexible adaptation of anti-TB therapy, and prolonged ECMO support within multidisciplinary care were key to clinical recovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13324-4","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:27:03Z","timestamp":1776256023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Landouzy sepsis in a young adult with multiorgan failure: successful ECMO-assisted management using an individualized antituberculous regimen"],"prefix":"10.1186","volume":"26","author":[{"given":"Lukas","family":"van de Sand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Dubler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana Luisa","family":"Aulenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina Vanessa","family":"Pirschtat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Hegerfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Zettler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"13324_CR1","unstructured":"Global tuberculosis report 2024 [https:\/\/www.who.int\/publications\/b\/74877]"},{"key":"13324_CR2","doi-asserted-by":"crossref","unstructured":"Sharma SK, Mohan A. Miliary tuberculosis. Microbiol Spectr. 2017;5(2).","DOI":"10.1128\/microbiolspec.TNMI7-0013-2016"},{"issue":"7","key":"13324_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(05)70163-8","volume":"5","author":"SK Sharma","year":"2005","unstructured":"Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis. 2005;5(7):415\u201330.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"13324_CR4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1378\/chest.12-1286","volume":"144","author":"S Kethireddy","year":"2013","unstructured":"Kethireddy S, Light RB, Mirzanejad Y, Maki D, Arabi Y, Lapinsky S, Simon D, Kumar A, Parrillo JE, Kumar A. Mycobacterium tuberculosis septic shock. Chest. 2013;144(2):474\u201382.","journal-title":"Chest"},{"key":"13324_CR5","first-page":"100900","volume":"28","author":"NG Binh","year":"2019","unstructured":"Binh NG, Manabe T, Co DX, Thach PT, Tuan DQ, Cuong BV, Tuyet LTD, Kudo K, Anh NQ. Tuberculosis-induced acute respiratory distress syndrome treated with veno-venous extracorporeal membrane oxygenation. Respir Med Case Rep. 2019;28:100900.","journal-title":"Respir Med Case Rep"},{"issue":"1","key":"13324_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13054-024-05110-y","volume":"28","author":"A Ait Hssain","year":"2024","unstructured":"Ait Hssain A, Petit M, Wiest C, Simon L, Al-Fares AA, Hany A, Garcia-Gomez DI, Besa S, Nseir S, Guervilly C, et al. Extracorporeal membrane oxygenation for tuberculosis-related acute respiratory distress syndrome: An international multicentre retrospective cohort study. Crit Care. 2024;28(1):332.","journal-title":"Crit Care"},{"issue":"2","key":"13324_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1378\/chest.12-1286","volume":"144","author":"S Kethireddy","year":"2013","unstructured":"Kethireddy S, Light RB, Mirzanejad Y, Maki D, Arabi Y, Lapinsky S, Simon D, Kumar A, Parrillo JE. Kumar A: <em>Mycobacterium tuberculosis<\/em> Septic Shock. Chest. 2013;144(2):474\u201382.","journal-title":"Chest"},{"issue":"3","key":"13324_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/02676591241249609","volume":"40","author":"SB Dave","year":"2025","unstructured":"Dave SB, Leiendecker E, Creel-Bulos C, Miller CF, Boorman DW, Javidfar J, Attia T, Daneshmand M, Jabaley CS, Caridi-Schieble M. Outcomes following additional drainage during veno-venous extracorporeal membrane oxygenation: A single-center retrospective study. Perfusion. 2025;40(3):647\u201356.","journal-title":"Perfusion"},{"issue":"3","key":"13324_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1056\/NEJMra1816149","volume":"381","author":"JH Hoofnagle","year":"2019","unstructured":"Hoofnagle JH, Bj\u00f6rnsson ES. Drug-Induced Liver Injury - Types and Phenotypes. N Engl J Med. 2019;381(3):264\u201373.","journal-title":"N Engl J Med"},{"key":"13324_CR10","doi-asserted-by":"publisher","first-page":"100590","DOI":"10.1016\/j.jctube.2026.100590","volume":"43","author":"M Sintusuwan","year":"2026","unstructured":"Sintusuwan M, Prueksapanich P, Suwanpimolkul G. Prevalence and risk factors associated with rifampicin-induced cholestasis jaundice among tuberculosis patients in high-incidence setting: A retrospective cohort study. J Clin Tuberc Other Mycobact Dis. 2026;43:100590.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"8","key":"13324_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s40265-014-0222-8","volume":"74","author":"A Alsultan","year":"2014","unstructured":"Alsultan A, Peloquin CA. Therapeutic drug monitoring in the treatment of tuberculosis: an update. Drugs. 2014;74(8):839\u201354.","journal-title":"Drugs"},{"issue":"1","key":"13324_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12890-023-02715-x","volume":"24","author":"R Idris","year":"2024","unstructured":"Idris R, Zielbauer AS, Koepsell J, Kloka J, Wetzstein N. Extracorporeal membrane oxygenation (ECMO) in patients with tuberculosis: systematic review and meta-analysis of 43 cases. BMC Pulm Med. 2024;24(1):47.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"13324_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1164\/rccm.202410-2096ST","volume":"211","author":"JJ Saukkonen","year":"2025","unstructured":"Saukkonen JJ, Duarte R, Munsiff SS, Winston CA, Mammen MJ, Abubakar I, Acu\u00f1a-Villaordu\u00f1a C, Barry PM, Bastos ML, Carr W, et al. Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS\/CDC\/ERS\/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med. 2025;211(1):15\u201333.","journal-title":"Am J Respir Crit Care Med"},{"key":"13324_CR14","volume-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","author":"Pyrazinamide","year":"2012","unstructured":"Pyrazinamide. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. edn. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"key":"13324_CR15","volume-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","author":"Rifampin","year":"2012","unstructured":"Rifampin. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. edn. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"issue":"3 Pt 1","key":"13324_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1164\/ajrccm.156.3.9609132","volume":"156","author":"PR Donald","year":"1997","unstructured":"Donald PR, Sirgel FA, Botha FJ, Seifart HI, Parkin DP, Vandenplas ML, Van de Wal BW, Maritz JS, Mitchison DA. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Am J Respir Crit Care Med. 1997;156(3 Pt 1):895\u2013900.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"13324_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40121-013-0009-3","volume":"2","author":"GJ Fox","year":"2013","unstructured":"Fox GJ, Menzies D. A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis. Infect Dis Ther. 2013;2(2):123\u201344.","journal-title":"Infect Dis Ther"},{"issue":"10362","key":"13324_CR18","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/S0140-6736(22)01883-9","volume":"400","author":"J Mok","year":"2022","unstructured":"Mok J, Lee M, Kim DK, Kim JS, Jhun BW, Jo K-W, Jeon D, Lee T, Lee JY, Park JS, et al. 9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2\/3 non-inferiority trial in South Korea. Lancet. 2022;400(10362):1522\u201330.","journal-title":"Lancet"},{"issue":"5","key":"13324_CR19","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00204-019-02407-8","volume":"93","author":"H Hong","year":"2019","unstructured":"Hong H, Dooley KE, Starbird LE, Francis HW, Farley JE. Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment. Arch Toxicol. 2019;93(5):1385\u201399.","journal-title":"Arch Toxicol"},{"issue":"1","key":"13324_CR20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1186\/s13054-020-03397-1","volume":"24","author":"D K\u00fchn","year":"2020","unstructured":"K\u00fchn D, Metz C, Seiler F, Wehrfritz H, Roth S, Alqudrah M, Becker A, Bracht H, Wagenpfeil S, Hoffmann M, et al. Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study. Crit Care. 2020;24(1):664.","journal-title":"Crit Care"},{"issue":"4","key":"13324_CR21","doi-asserted-by":"publisher","first-page":"100211","DOI":"10.1016\/j.opresp.2022.100211","volume":"4","author":"L Cendon","year":"2022","unstructured":"Cendon L, Rafecas Codern A, de la Rosa D, Castellv\u00ed I, Spagnolo P, Castillo D. Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia. Open Respir Arch. 2022;4(4):100211.","journal-title":"Open Respir Arch"},{"key":"13324_CR22","doi-asserted-by":"publisher","first-page":"100341","DOI":"10.1016\/j.jctube.2022.100341","volume":"29","author":"K Wakamatsu","year":"2022","unstructured":"Wakamatsu K, Nagata N, Kumazoe H, Honjo S, Hamada M, Katsuki K, Hara M, Nagaoka A, Noda N, Kiyotani R, et al. Efficacy of steroid pulse therapy for miliary tuberculosis complicated by acute respiratory distress syndrome. J Clin Tuberc Other Mycobact Dis. 2022;29:100341.","journal-title":"J Clin Tuberc Other Mycobact Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13324-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:52:43Z","timestamp":1776325963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13324-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13324"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13324-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval from our hospital\u2019s review committee is not required for case reports, and written informed consent was obtained from the patient. The research was conducted in accordance with the principles outlined in the Declaration of Helsinki on medical research involving human subjects, and all procedures were followed in compliance with ethical guidelines and standards of good clinical practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. There are no name tags or identity reveals throughout this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"769"}}